ENANTA PHARMACEUTICALS, INC Payments to Acquire Marketable Securities
ENANTA PHARMACEUTICALS, INC (ENTA) reported Payments to Acquire Marketable Securities of $216.08 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-08-12
- ENANTA PHARMACEUTICALS, INC payments to acquire marketable securities for the quarter ending 2026-06-30 was $25.51M, a 70.33% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC payments to acquire marketable securities for the quarter ending 2026-03-31 was $41.95M, a 23.75% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC payments to acquire marketable securities for the quarter ending 2025-12-31 was $148.62M.
- ENANTA PHARMACEUTICALS, INC payments to acquire marketable securities for the quarter ending 2025-09-30 was $68.62M.
- ENANTA PHARMACEUTICALS, INC payments to acquire marketable securities for fiscal 2025 was $209.63M, a 31.78% decline from fiscal 2024.
- ENANTA PHARMACEUTICALS, INC payments to acquire marketable securities for fiscal 2024 was $307.28M, a 17.71% decline from fiscal 2023.
- ENANTA PHARMACEUTICALS, INC payments to acquire marketable securities for fiscal 2023 was $373.39M, a 117.79% increase from fiscal 2022.
- ENANTA PHARMACEUTICALS, INC payments to acquire marketable securities for fiscal 2022 was $171.45M, a 44.22% decline from fiscal 2021.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $25.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | $67.46M derived: sum of 2 quarters · filed 2026-08-12 | $216.08M 10-Q · filed 2026-08-12 | $284.70M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $41.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $190.57M 10-Q · filed 2026-05-13 | $259.19M derived: sum of 3 quarters · filed 2026-05-13 | $345.19M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $148.62M 10-Q · filed 2026-02-11 | $217.25M derived: sum of 2 quarters · filed 2026-02-11 | $303.24M derived: sum of 3 quarters · filed 2026-08-12 | $358.25M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-09-30 | $68.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $154.61M derived: sum of 2 quarters · filed 2026-08-12 | $209.63M derived: sum of 3 quarters · filed 2026-08-12 | $209.63M 10-K · filed 2025-11-19 |
| 2025-06-30 | $85.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | $141.01M derived: sum of 2 quarters · filed 2026-08-12 | $141.01M 10-Q · filed 2026-08-12 | $141.01M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $55.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $55.02M 10-Q · filed 2026-05-13 | $55.02M derived: sum of 3 quarters · filed 2026-05-13 | $150.16M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $0.00 10-Q · filed 2026-02-11 | -$1.00K derived: sum of 2 quarters · filed 2026-02-11 | $95.15M derived: sum of 3 quarters · filed 2026-02-11 | $160.44M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $95.15M derived: sum of 2 quarters · filed 2025-11-19 | $160.44M derived: sum of 3 quarters · filed 2025-11-19 | $307.28M 10-K · filed 2025-11-19 |
| 2024-06-30 | $95.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13 | $160.44M derived: sum of 2 quarters · filed 2025-08-13 | $307.28M 10-Q · filed 2025-08-13 | $413.40M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-03-31 | $65.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $212.13M 10-Q · filed 2025-05-14 | $318.25M derived: sum of 3 quarters · filed 2025-11-19 | $494.90M derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-12-31 | $146.84M 10-Q · filed 2025-02-12 | $252.96M derived: sum of 2 quarters · filed 2025-11-19 | $429.61M derived: sum of 3 quarters · filed 2025-11-19 | $452.86M derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-09-30 | $106.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $282.76M derived: sum of 2 quarters · filed 2025-11-19 | $306.02M derived: sum of 3 quarters · filed 2025-11-19 | $373.39M 10-K · filed 2025-11-19 |
| 2023-06-30 | $176.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-07 | $199.90M derived: sum of 2 quarters · filed 2024-08-07 | $267.27M 10-Q · filed 2024-08-07 | $276.01M derived: sum of 4 quarters · filed 2024-11-27 |
| 2023-03-31 | $23.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | $90.63M 10-Q · filed 2024-05-08 | $99.36M derived: sum of 3 quarters · filed 2024-11-27 | $137.44M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-12-31 | $67.38M 10-Q · filed 2024-02-08 | $76.11M derived: sum of 2 quarters · filed 2024-11-27 | $114.19M derived: sum of 3 quarters · filed 2024-11-27 | $175.92M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-09-30 | $8.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $46.81M derived: sum of 2 quarters · filed 2024-11-27 | $108.54M derived: sum of 3 quarters · filed 2024-11-27 | $171.45M 10-K · filed 2024-11-27 |
| 2022-06-30 | $38.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $99.81M derived: sum of 2 quarters · filed 2023-08-08 | $162.71M 10-Q · filed 2023-08-08 | $162.11M derived: sum of 4 quarters · filed 2023-11-22 |
| 2022-03-31 | $61.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-09 | $124.63M 10-Q · filed 2023-05-09 | $124.03M derived: sum of 3 quarters · filed 2023-11-22 | $260.39M derived: sum of 4 quarters · filed 2023-11-22 |
| 2021-12-31 | $62.90M 10-Q · filed 2023-02-08 | $62.30M derived: sum of 2 quarters · filed 2023-11-22 | $198.66M derived: sum of 3 quarters · filed 2023-11-22 | $265.58M derived: sum of 4 quarters · filed 2023-11-22 |
| 2021-09-30 | -$601.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-22 | $135.76M derived: sum of 2 quarters · filed 2023-11-22 | $202.67M derived: sum of 3 quarters · filed 2023-11-22 | $307.35M 10-K · filed 2023-11-22 |
| 2021-06-30 | $136.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-08 | $203.28M derived: sum of 2 quarters · filed 2022-08-08 | $307.95M 10-Q · filed 2022-08-08 | $378.92M derived: sum of 4 quarters · filed 2022-11-23 |
| 2021-03-31 | $66.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-09 | $171.59M 10-Q · filed 2022-05-09 | $242.55M derived: sum of 3 quarters · filed 2022-11-23 | $338.25M derived: sum of 4 quarters · filed 2022-11-23 |
| 2020-12-31 | $104.67M 10-Q · filed 2022-02-10 | $175.64M derived: sum of 2 quarters · filed 2022-11-23 | $271.34M derived: sum of 3 quarters · filed 2022-11-23 | $325.77M derived: sum of 4 quarters · filed 2022-11-23 |
| 2020-09-30 | $70.97M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-23 | $166.67M derived: sum of 2 quarters · filed 2022-11-23 | $221.09M derived: sum of 3 quarters · filed 2022-11-23 | $338.55M 10-K · filed 2022-11-23 |
| 2020-06-30 | $95.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-09 | $150.13M derived: sum of 2 quarters · filed 2021-08-09 | $267.59M 10-Q · filed 2021-08-09 | $463.52M derived: sum of 4 quarters · filed 2021-11-24 |
| 2020-03-31 | $54.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-10 | $171.88M 10-Q · filed 2021-05-10 | $367.81M derived: sum of 3 quarters · filed 2021-11-24 | $449.48M derived: sum of 4 quarters · filed 2021-11-24 |
| 2019-12-31 | $117.46M 10-Q · filed 2021-02-09 | $313.39M derived: sum of 2 quarters · filed 2021-11-24 | $395.06M derived: sum of 3 quarters · filed 2021-11-24 | $547.23M derived: sum of 4 quarters · filed 2021-11-24 |
| 2019-09-30 | $195.93M derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | $277.60M derived: sum of 2 quarters · filed 2021-11-24 | $429.77M derived: sum of 3 quarters · filed 2021-11-24 | $549.31M 10-K · filed 2021-11-24 |
| 2019-06-30 | $81.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-10 | $233.84M derived: sum of 2 quarters · filed 2020-08-10 | $353.38M 10-Q · filed 2020-08-10 | $467.41M derived: sum of 4 quarters · filed 2020-11-25 |
| 2019-03-31 | $152.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-11 | $271.71M 10-Q · filed 2020-05-11 | $385.74M derived: sum of 3 quarters · filed 2020-11-25 | $465.09M derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-12-31 | $119.55M 10-Q · filed 2020-02-10 | $233.57M derived: sum of 2 quarters · filed 2020-11-25 | $312.93M derived: sum of 3 quarters · filed 2020-11-25 | $357.94M derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-09-30 | $114.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | $193.38M derived: sum of 2 quarters · filed 2020-11-25 | $238.39M derived: sum of 3 quarters · filed 2020-11-25 | $293.10M 10-K · filed 2020-11-25 |
| 2018-06-30 | $79.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-09 | $124.37M derived: sum of 2 quarters · filed 2019-08-09 | $179.08M 10-Q · filed 2019-08-09 | $244.22M derived: sum of 4 quarters · filed 2019-11-27 |
| 2018-03-31 | $45.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10 | $99.72M 10-Q · filed 2019-05-10 | $164.87M derived: sum of 3 quarters · filed 2019-11-27 | $199.82M derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-12-31 | $54.71M 10-Q · filed 2019-02-08 | $119.86M derived: sum of 2 quarters · filed 2019-11-27 | $154.81M derived: sum of 3 quarters · filed 2019-11-27 | $232.41M derived: sum of 4 quarters · filed 2019-11-27 |
| 2017-09-30 | $65.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-27 | $100.10M derived: sum of 2 quarters · filed 2019-11-27 | $177.70M derived: sum of 3 quarters · filed 2019-11-27 | $251.37M 10-K · filed 2019-11-27 |
| 2017-06-30 | $34.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-09 | $112.55M derived: sum of 2 quarters · filed 2018-08-09 | $186.22M 10-Q · filed 2018-08-09 | $228.16M derived: sum of 4 quarters · filed 2018-11-29 |
| 2017-03-31 | $77.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-10 | $151.27M 10-Q · filed 2018-05-10 | $193.21M derived: sum of 3 quarters · filed 2018-11-29 | $259.14M derived: sum of 4 quarters · filed 2018-11-29 |
| 2016-12-31 | $73.67M 10-Q · filed 2018-02-09 | $115.61M derived: sum of 2 quarters · filed 2018-11-29 | $181.54M derived: sum of 3 quarters · filed 2018-11-29 | $231.48M derived: sum of 4 quarters · filed 2018-11-29 |
| 2016-09-30 | $41.94M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-29 | $107.87M derived: sum of 2 quarters · filed 2018-11-29 | $157.81M derived: sum of 3 quarters · filed 2018-11-29 | $192.43M 10-K · filed 2018-11-29 |
| 2016-06-30 | $65.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09 | $115.87M derived: sum of 2 quarters · filed 2017-08-09 | $150.49M 10-Q · filed 2017-08-09 | $191.21M derived: sum of 4 quarters · filed 2017-12-11 |
| 2016-03-31 | $49.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-10 | $84.56M 10-Q · filed 2017-05-10 | $125.28M derived: sum of 3 quarters · filed 2017-12-11 | $145.03M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-12-31 | $34.62M 10-Q · filed 2017-02-09 | $75.34M derived: sum of 2 quarters · filed 2017-12-11 | $95.09M derived: sum of 3 quarters · filed 2017-12-11 | $222.77M derived: sum of 4 quarters · filed 2017-12-11 |
| 2015-09-30 | $40.72M derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-11 | $60.47M derived: sum of 2 quarters · filed 2017-12-11 | $188.15M derived: sum of 3 quarters · filed 2017-12-11 | $196.30M 10-K · filed 2017-12-11 |
| 2015-06-30 | $19.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09 | $147.43M derived: sum of 2 quarters · filed 2016-08-09 | $155.58M 10-Q · filed 2016-08-09 | $168.24M derived: sum of 4 quarters · filed 2016-12-09 |
| 2015-03-31 | $127.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-10 | $135.83M 10-Q · filed 2016-05-10 | $148.49M derived: sum of 3 quarters · filed 2016-12-09 | $209.66M derived: sum of 4 quarters · filed 2016-12-09 |
| 2014-12-31 | $8.15M 10-Q · filed 2016-02-09 | $20.81M derived: sum of 2 quarters · filed 2016-12-09 | $81.99M derived: sum of 3 quarters · filed 2016-12-09 | $96.34M derived: sum of 4 quarters · filed 2016-12-09 |
| 2014-09-30 | $12.65M derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-09 | $73.83M derived: sum of 2 quarters · filed 2016-12-09 | $88.18M derived: sum of 3 quarters · filed 2016-12-09 | $98.41M 10-K · filed 2016-12-09 |
| 2014-06-30 | $61.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10 | $75.53M derived: sum of 2 quarters · filed 2015-08-10 | $85.75M 10-Q · filed 2015-08-10 | $101.39M derived: sum of 4 quarters · filed 2015-12-11 |
| 2014-03-31 | $14.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | $24.57M 10-Q · filed 2015-05-08 | $40.21M derived: sum of 3 quarters · filed 2015-12-11 | $94.75M derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-12-31 | $10.22M 10-Q · filed 2015-02-06 | $25.86M derived: sum of 2 quarters · filed 2015-12-11 | $80.40M derived: sum of 3 quarters · filed 2015-12-11 | $112.97M derived: sum of 4 quarters · filed 2015-12-11 |
| 2013-09-30 | $15.63M derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-11 | $70.18M derived: sum of 2 quarters · filed 2015-12-11 | $102.75M derived: sum of 3 quarters · filed 2015-12-11 | $115.89M 10-K · filed 2015-12-11 |
| 2013-06-30 | $54.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | $87.11M derived: sum of 2 quarters · filed 2014-08-12 | $100.25M 10-Q · filed 2014-08-12 | $101.70M derived: sum of 4 quarters · filed 2014-12-11 |
| 2013-03-31 | $32.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-12 | $45.71M 10-Q · filed 2014-05-12 | $47.15M derived: sum of 3 quarters · filed 2014-12-11 | $63.85M derived: sum of 4 quarters · filed 2014-12-11 |
| 2012-12-31 | $13.14M 10-Q · filed 2014-02-13 | $14.59M derived: sum of 2 quarters · filed 2014-12-11 | $31.29M derived: sum of 3 quarters · filed 2014-12-11 | |
| 2012-09-30 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-11 | $18.14M derived: sum of 2 quarters · filed 2014-12-11 | $47.69M 10-K · filed 2014-12-11 | |
| 2012-06-30 | $16.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-12 | $46.25M 10-Q · filed 2013-08-12 | ||
| 2012-03-31 | $29.55M 10-Q · filed 2013-05-15 | |||
| 2011-09-30 | $33.57M 10-K · filed 2013-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |